RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: COVID-19 Investor Presentation, page-8

  1. TheSanDiegoKid
    724 Posts.
    lightbulb Created with Sketch. 356
    clock Created with Sketch.
    22/03/22
    14:17
    Post #: 60343439
    They are looking at funding for the upcoming blind trials to fast tracks to commercialisation. That may come in the form of CR, government funding or a strategic partner for exclusive licensing rights
    Last edited by TheSanDiegoKid: 22/03/22
    RAP Price at posting: 8.9¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.